C1S and chronic inflammatory demyelinating polyradiculoneuropathy: However, recent work provided support for testing C1s inhibition in a clinical trial of an autoimmune demyelinating neuropathy, CIDP (NCT04658472), and suggests great potential for microphysiological systems use for translational research leading to IND generation [52].